[The use of transdermal opioids in patients in oncological remission suffering from chronic pain].
Today, oncological patients in remission are becoming more numerous and about a third have chronic pain from various etiologies. In the objective of a comprehensive management plan for chronic pain in these patients, therapeutic goals, conditions and terms of prescription of opioids in the long-term should be discussed. The transdermal route may be an attractive alternative when analgesic treatment of moderate to severe pain is balanced. It provides increased comfort in selected patients in whom oral administration is difficult or a polypharmacy troublesome. Risks/benefits of a prescription of opioids in the treatment of chronic pain in patients in oncological remission should be re-evaluated and included in a multimodal support.
Lia
L
Oberlé
Christophe
C
Luthy
Angela
A
Pugliesi
Sophie
S
Pautex
Valérie
V
Piguet
D000279:Administration, Cutaneous; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D059350:Chronic Pain / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology / Q000534:rehabilitation; D012074:Remission Induction
D000701:Analgesics, Opioid